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Neighborhood Characteristics and Colorectal Cancer
Survivors’ Quality of Care
Ulrike Boehmer,1,* Jennifer Potter,2–4 Melissa A. Clark,5 Al Ozonoff,3,6 Rachel M. Ceballos,7
Michael Winter,8 and Kevan L. Hartshorn9
Abstract
Purpose: Quality cancer care entails receipt of a Survivorship Care Plan (SCP). The purpose of this study was to
determine differences in SCP delivery by patient-level and neighborhood characteristics.
Methods: We obtained California cancer registry data on individuals who were diagnosed with stage I, II, or III
colorectal cancer (CRC) between 2012 and 2015 and resided in predetermined geographic areas. We then mailed
them a questionnaire, which queried about receipt of a SCP and its content. SCP was deﬁned by content, as
summary of cancer treatment, cancer surveillance recommendations, and/or an individualized preventive
care. Using logistic regression modeling, each measure of SCP, as well as the summary measure (none vs.
any), was evaluated by person-level characteristics. Subsequently, neighborhood-level characteristics were
added to the model to explore their additional value.
Results: Overall 80% of CRC survivors received a SCP. Receipt of SCPs was associated with person-level charac-
teristics, while neighborhood characteristics did not make an additional contribution. Young, male employed
survivors and those with more recent diagnoses or later cancer stages had greater odds of receiving a SCP.
Conclusion:When providing SCPs, health care providers prioritize patient groups who they may perceive as vul-
nerable or likely to beneﬁt from SCPs.
Keywords: survivorship care plan; colorectal cancer; quality of cancer care
Introduction
In 2006, the Institute of Medicine (IOM) report, ‘‘From
Cancer Patient to Cancer Survivor,’’ recommended that
each cancer patient receive a Survivorship Care Plan
(SCP) upon completion of treatment.1 Ideally, a SCP
should include a summary of treatments, follow-up
recommendations, and individualized recommenda-
tions for maintaining health and well-being. A 2013
IOM report deﬁnes ‘‘high quality cancer care’’ as meet-
ing the needs of patients with cancer by providing them
with understandable information to facilitate their en-
gagement in informed decision making from the time
of diagnosis through treatment and survivorship.2 Con-
sistent with this goal, the SCP is a key document thought
to facilitate survivors’ engagement in care and transition
from active treatment to long-term cancer survivorship.
The Commission on Cancer (CoC) issued Standard
3.3, which requires accredited cancer programs to provide
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a SCP to patients with stage I, II, or III cancers that are
treated with curative intent, and initially outlined a
stepwise implementation schedule stipulating that
10% or more patients receive a SCP by 2015, 25% or
more by 2016, 50% or more by 2017, and 75% or
more by 2018.3 Due to implementation challenges,
the CoC subsequently lowered the 2018 goal from
75% to 50% of patients. Divergent from this, California
set its own, more ambitious, targets of 79.1% of patients
to receive a SCP by 2015, an increase over the 2011 rate
of 71.9%.4
The widespread endorsement of SCPs catalyzed ob-
servational studies and randomized interventions that
examined the beneﬁts of SCPs.5,6 The literature on
the beneﬁts of SCPs is equivocal. A recent review of
13 randomized studies reported negative results for
one study, in that recipients of SCPs reported more
symptoms and a greater emotional impact of their can-
cer than those who did not receive a SCP,6 and seven
studies had null ﬁndings, indicating that survivors
who were randomized to receive a SCP did not differ
in outcomes from those who did not receive a SCP.6
Studies of SCP delivery concluded that the receipt of
SCPs is linked to patient-level factors.7 These ﬁndings
have been conﬁrmed in recent studies, which found
that younger, non-white, more educated, and higher in-
come patients have greater odds of receiving SCPs.8,9
However, study ﬁndings have been inconsistent,8,9 and
the survivors in these studies had diverse cancer types
and were geographically dispersed. This may bias ﬁnd-
ings in that cancer type and gender cannot be disaggre-
gated, and geographic variations in SCP receipt may
impact ﬁndings. To address the equitability of SCP de-
livery, we focused only on colorectal cancer (CRC) sur-
vivors in the state of California.
In recent years, an increasing number of studies have
focused on the link between location and health, iden-
tifying associations yet also variation in the magnitude
and direction of the effect.10 A review of studies with
multilevel analyses of cancer outcomes concluded
that census tracts were the most commonly used geo-
graphic scale, cancer screening the most frequent can-
cer outcome, and 48% of studies focused on breast
cancer, while 25% focused on CRC.11 Prior studies of
CRC in California have shown that individuals living
in lower income neighborhoods have worse survival
than those in higher income neighborhoods, while sub-
sequent analyses showed that the link between neigh-
borhood poverty and shorter survival was mediated
by health insurance for women, but not men.12,13 Fur-
thermore, when focusing on CRC quality of care, de-
ﬁned as number of regional lymph nodes examined
and wait times for surgery and chemotherapy, living
in poor neighborhoods was linked to worse cancer
care.12,13 This study builds on this line of research, by
performing multilevel analyses to identify which
person-level and neighborhood factors best explain
quality of care, deﬁned as the receipt of a SCP among
California CRC survivors.
Methods
All aspects of the study were approved by both the Bos-
ton University and the California Department of Public
Health Institutional Review Boards.
Study setting
Eligible cases were from the California state cancer reg-
istry and had a diagnosis of colon or rectal adenocarci-
noma in years 2012–2015; stage I, II, or III at diagnosis;
and age 21 and older at diagnosis. We then reduced the
volume of cases, by restricting ourselves to geographic
areas, that is, county subdivisions, with high numbers
of CRC cases and same-sex partnered households to
meet the aims of a larger parent study, which sought
to examine variation in CRC survivors’ needs by sexual
orientation.
Recruitment process and data collection
After we received data on all potentially eligible cases
from the California cancer registry for the selected geo-
graphic regions, we began contact procedures. The ﬁrst
contact consisted of a mailed package that entailed a
brochure from the California registry explaining the
function of the registry, a consent form, a study recruit-
ment letter, a short survey, and a self-addressed stamped
return envelope. The recruitment letter explained the
purpose of the study, provided information about the
means to opt out of the study, and announced that a
member of the study team would call individuals who
did not opt out of the study and did not return the
questionnaire to conduct the screening survey through
the telephone. A few weeks after sending the mailing,
we initiated the ﬁrst of a maximum of 10 call attempts,
including three voice mail messages, to complete the
screening survey. Between October 2015 and Decem-
ber 2016, we mailed study packages to 6978 patients.
Of these 1040 opted out or refused participation
upon contact, 429 had a language barrier, 106 were de-
ceased, 77 had a cognitive impairment, 17 had a hear-
ing impairment, and we were unable to make contact
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with 2786 due to bad addresses, nonworking phone
numbers, or having made the maximum number of
call attempts. We obtained 2523 completed question-
naires. We excluded 159 individuals who reported
never having had cancer and one individual who was
ineligible due to age, which resulted in a sample of
2363 California CRC survivors.
Measures
All clinical and selected demographic data were
obtained from the cancer registry, which cancer regis-
trars derived from patients’ medical records. Clinical
information consisted of date of diagnosis, cancer
site, stage at diagnosis, and number of excised lymph
nodes. Treatment data entailed receipt of surgery, che-
motherapy, and or radiation therapy, which we sum-
marized into a variable that distinguished surgery
only treatment from more extensive treatments. In
this sample, 40 cases had multiple primary tumors,
which were reviewed by the oncologist on our study
to then assign appropriate clinical characteristics for
each case with multiple tumors. We used the earliest di-
agnosis date, retained both primary sites if applicable,
assigned the worst recorded cancer stage, and retained
all treatments that were received. For each cancer
case, we obtained an identiﬁer for the facility at
which the diagnosis and ﬁrst treatment occurred
from the cancer registry. We then linked the facility
to the hospital annual utilization data, which are
available from the California’s Ofﬁce of Statewide
Health Planning and Development to derive a vari-
able that distinguished teaching hospitals from non-
teaching hospitals and size of the facility. Size of the
facility was determined by the licensed number of med-
ical and surgical beds and was categorized into tertiles:
small (16–157 beds), medium (160–261), and large
(263–591). From cancer registry demographic data,
we obtained age at diagnosis; race/ethnicity categorized
into non-HispanicWhite, non-Hispanic Black, Hispanic,
Asian/Paciﬁc Islander, and other/unknown; and marital
status, categorized as married, never married, separated,
divorced, or widowed, and unknown status. From col-
lected survey data, we obtained employment status.
From individuals’ census tract at diagnosis, we de-
rived neighborhood level descriptors of socioeconomic
status. The ﬁrst was the percent of the population
below the poverty level. Two others captured spatial
social and economic polarization, summarized as an
index of concentration at the extremes (ICE) for in-
come and race/ethnicity.14,15 The ICE measures range
from 1, which captures the most disadvantaged, to
1, which reﬂects the most advantaged, while a value
of 0 indicates an equal number of persons in the best
off and worst off categories.15
Our outcome, SCP, was assessed using questions
from the National Health Interview Survey with yes/
no response options7: (1) receipt of a written summary
of received treatments, which we refer to as treatment
SCP; (2) receipt of written instructions of who to see
for follow-up care after the completion of treatment,
which we refer to as follow-up SCP; and (3) receipt
of individualized recommendations for a healthy life-
style, such as exercising and not-smoking, which we
refer to as individualized SCP. Individuals who responded
not knowing whether they received a SCP were counted
as not having received a SCP. To provide an overall es-
timate of SCP receipt, we created a composite measure
of SCP types 1–3 (none vs. any SCP).
Statistical analysis
We examined the characteristics of the sample using
descriptive statistics, including proportions for categor-
ical variables and means, standard deviations, medians,
and interquartile ranges for continuous variables. For
each outcome variable, we used stepwise logistic regres-
sion analyses to ﬁt a base model, including the following
independent variables: sex, age at diagnosis, years since
diagnosis, primary site, stage, treatment summary, num-
ber of nodes examined, race/ethnicity, marital status,
and employment. Inclusion and exclusion of indepen-
dent variables in the model were determined by Akaike
information criterion (AIC) to determine best model
ﬁt.16 Each geographic descriptor was then added one
by one to the best ﬁtting base model, and model ﬁt
based on AIC criteria was examined and compared to
AIC of the base model. All analyses were performed
using SAS/STAT software, version 9.4 of the SAS System
for Microsoft Windows.
Results
The sample of California cancer survivors consisted of
44% men and 56% women, three-quarters were Non-
Hispanic White, the majority was married, and about
half of the sample self-reported as retired (Table 1).
The average age at diagnosis was 63 years, with the ma-
jority diagnosed after age 50. The majority of survivors
had a diagnosis of colon cancer, about 2% had multiple
tumors, and cancer stage was equally distributed be-
tween stages I, II, and III. Almost 60% of survivors
were treated with surgery only, while 26% were treated
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Table 1. Characteristics of California Colorectal Cancer Survivors (N = 2363)
Overall Men Women
N= 2363 N = 1039 (44%) N =1324 (56%)
N (%) N (%) N (%)
Demographics
Race (registry)
Non-Hispanic White 1828 (77.4) 803 (77.3) 1025 (77.4)
Non-Hispanic Black 182 (7.7) 77 (7.4) 105 (7.9)
Hispanic 120 (5.1) 46 (4.4) 74 (5.6)
Asian/Paciﬁc Islander 201 (8.5) 105 (10.1) 96 (7.3)
American Indian/other/unknown 32 (1.4) 8 (0.8) 24 (1.8)
Marital status (registry)
Married 1272 (57.1) 634 (63.9) 638 (51.6)
Separated/divorced/widowed 481 (21.6) 123 (12.4) 358 (28.9)
Single, never married 476 (21.4) 235 (23.7) 241 (19.5)
Missing 134 47 87
Employment (screener)
Employed 873 (37.4) 447 (43.6) 426 (32.6)
Looking for work/other 94 (4.0) 30 (2.9) 64 (4.9)
Retired 1157 (49.6) 463 (45.1) 694 (53.1)
On disability/unable to work 209 (9.0) 86 (8.4) 123 (9.4)
Missing 30 13 17
Clinical characteristics
Age at diagnosis
Range 22–97 23–94 22–97
Median (IQR) 65 (55, 72) 64 (55, 72) 65 (56, 73)
Mean (SD) 63.4 (11.8) 62.9 (11.7) 63.8 (11.8)
21–49 years old 288 (12.2) 134 (12.9) 154 (11.6)
50–64 years old 882 (37.3) 408 (39.3) 474 (35.8)
65 years and older 1193 (50.5) 497 (47.8) 696 (52.6)
Primary site
Colon 1621 (68.6) 672 (64.7) 949 (71.7)
Rectum 731 (30.9) 358 (34.5) 373 (28.2)
Both 11 (0.5) 9 (0.9) 2 (0.1)
Multiple tumors 39 (1.7) 23 (2.2) 16 (1.3)
Stage at diagnosis
Stage I 746 (31.6) 335 (32.2) 411 (31.0)
Stage II 726 (30.7) 306 (29.5) 420 (31.7)
Stage III 891 (37.7) 398 (38.3) 493 (37.2)
Regional nodes examined
None 221 (9.4) 111 (10.8) 110 (8.3)
1–5 71 (3.0) 34 (3.3) 37 (2.8)
6–10 142 (6.0) 58 (5.6) 84 (6.4)
11–14 522 (17.9) 186 (18.0) 236 (17.8)
15 + 1499 (63.7) 643 (62.3) 856 (64.7)
Unknown/missing 8 7 1
Treatment summary
Surgery only 1309 (55.4) 553 (53.2) 756 (57.1)
Chemotherapy/no radiation 620 (26.2) 273 (26.3) 347 (26.2)
Chemotherapy+ radiation 347 (14.7) 172 (16.5) 175 (13.2)
Other/unknown 87 (3.7) 41 (4.0) 46 (3.5)
Time since diagnosis (years)
Range 1.1–4.6 1.1–4.6 1.1–4.6
Median (IQR) 2.8 (1.9, 3.5) 2.8 (1.8, 3.5) 2.9 (2.0, 3.5)
Mean (SD) 2.8 (0.9) 2.7 (0.9) 2.8 (0.9)
Structural characteristics
ICE for race
Range 0.77–1.00 0.77–1.00 0.77–0.96
Median (IQR) 0.59 (0.33, 0.75) 0.57 (0.31, 0.74) 0.59 (0.33, 0.75)
Mean (SD) 0.50 (0.31) 0.50 (0.31) 0.51 (0.31)
ICE for income
Range 1.00–0.84 1.00–0.84 0.72–0.84
Median (IQR) 0.17 (0.03, 0.36) 0.18 (0.02, 0.37) 0.15 (0.04, 0.36)
Mean (SD) 0.16 (0.28) 0.17 (0.28) 0.15 (0.27)
Percent below poverty level
Range 0–80.3 0–80.3 0.1–62.7
Median (IQR) 9.4 (5.4, 15.9) 9.5 (5.5, 16.0) 9.2 (5.3, 15.9)
(continued)
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with chemotherapy, and 15% had chemotherapy and ra-
diation treatment. Study contact with survivors occurred
on average just before they were 3 years postdiagnosis.
The mean value of the ICE for race indicated that sur-
vivors lived in areas with a greater number of white res-
idents, and the ICE for income showed that these areas
were ﬁnancially better off. Survivors lived in areas in
which on average 12% of residents lived below the pov-
erty level. One quarter of survivors received their diagno-
sis and ﬁrst course of treatment at teaching hospitals
with cases distributed across facilities of all sizes.
Twenty percent of survivors reported receiving no
SCP irrespective of type. Among those receiving an
SCP, the percentage of those receiving various types
of SCP was relatively consistent, with 50% reporting re-
ceipt of a treatment summary, 56% a follow-up SCP,
and 56% an individualized SCP.
The base model in Table 2 summarizes individual-
level explanatory factors that best explain the receipt
of a treatment SCP. Younger, male, black or Hispanic,
more recently diagnosed survivors, and those with a
later stage of cancer at the time of diagnosis had a greater
likelihood of receiving a treatment SCP than older, fe-
male, non-Hispanic White survivors with greater time
elapsed since diagnosis and those with earlier stage dis-
ease. Adding any of the three neighborhood characteris-
tics to this best ﬁtting model composed of individual
factors did not improve model ﬁt for receipt of a
Table 1. (Continued)
Overall Men Women
N = 2363 N= 1039 (44%) N = 1324 (56%)
N (%) N (%) N (%)
Mean (SD) 12.0 (9.2) 12.0 (9.2) 11.9 (9.2)
Teaching hospital
Yes 540 (25.1) 273 (29.1) 267 (22.1)
No 1608 (74.9) 666 (70.9) 942 (77.9)
Missing 215 100 115
Hospital size
Low 717 (33.4) 252 (26.8) 465 (38.5)
Medium 695 (32.4) 320 (34.1) 375 (31.0)
High 736 (34.3) 367 (39.1) 369 (30.5)
Missing 215 100 115
ICE, index of concentration at the extremes; IQR, interquartile range; SD, standard deviation.
Table 2. Explanatory Factors for Receipt of a Written Summary of Received Treatments (Treatment Survivorship Care Plan)
Base model Adding ICE race Adding ICE income Adding poverty level
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Sex
Male 1.15 (0.98–1.36) 1.15 (0.98–1.36) 1.15 (0.98–1.36) 1.15 (0.98–1.36)
Female REF REF REF REF
Race
White REF REF REF REF
Black 1.46 (1.07–1.99) 1.54 (1.09–2.18) 1.47 (1.07–2.01) 1.46 (1.06–2.01)
Hispanic 1.93 (1.30–2.88) 1.98 (1.32–2.97) 1.94 (1.30–2.89) 1.93 (1.29–2.88)
Asian/Paciﬁc Islander 1.19 (0.88–1.60) 1.22 (0.90–1.67) 1.19 (0.88–1.60) 1.19 (0.88–1.60)
Other/unknown 1.60 (0.78–3.27) 1.63 (0.80–3.35) 1.60 (0.78–3.28) 1.59 (0.78–3.27)
Age at diagnosis
21–49 1.27 (0.97–1.67) 1.27 (0.97–1.67) 1.27 (0.97–1.67) 1.27 (0.97–1.67)
50–64 REF REF REF REF
65+ 0.85 (0.71–1.01) 0.85 (0.71–1.01) 0.85 (0.71–1.01) 0.85 (0.71–1.01)
Years since diagnosis 0.88 (0.80–0.96) 0.88 (0.80–0.97) 0.88 (0.80–0.97) 0.88 (0.80–0.97)
Stage
I REF REF REF REF
II 0.97 (0.79–1.19) 0.97 (0.79–1.19) 0.97 (0.79–1.19) 0.97 (0.78–1.19)
III 1.14 (0.93–1.38) 1.13 (0.93–1.38) 1.14 (0.93–1.38) 1.14 (0.93–1.38)
ICE race 1.12 (0.82–1.52)
ICE income 1.01 (0.74–1.38)
Poverty 1.00 (0.99–1.01)
Model AIC 3216.702 3218.194 3218.695 3218.698
AIC, Akaike information criterion; CI, conﬁdence interval; OR, odds ratio; REF, reference group.
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treatment plan. Furthermore, none of the geographic
factors changed any of the individual factors in the
strength or direction of the association.
Survivors who were not married, older at diagnosis,
or looking for/unable to work were less likely to receive
a follow-up SCP than thosewhoweremarried, diagnosed
between ages 50 and 64, or employed, while survivors
withmore nodes examined and receivingmore extensive
treatments had a greater likelihood of receiving a follow-
up SCP than survivors with fewer nodes or those treated
with surgery only (Table 3). None of the neighborhood
characteristics changed the individual level factors in
magnitude or direction and did not improve the best ﬁt-
ting explanatory model of follow-up SCP.
Male survivors with more recent diagnoses, more
examined nodes, and more extensive cancer treatment
Table 3. Explanatory Factors for Receipt of Written Instructions of Who to See for Follow-Up Care After the Completion
of Treatment (Follow-Up Survivorship Care Plan)
Base model Adding ICE race Adding ICE income Adding poverty level
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Marital status
Single 0.78 (0.63–0.97) 0.77 (0.62–0.96) 0.79 (0.63–0.99) 0.78 (0.62–0.97)
Married REF REF REF REF
Separated/divorced/widowed 0.79 (0.63–0.98) 0.77 (0.62–0.96) 0.79 (0.64–0.99) 0.78 (0.63–0.98)
Employment
Employed REF REF REF REF
Looking for work 0.65 (0.41–1.00) 0.64 (0.41–1.00) 0.65 (0.41–1.01) 0.64 (0.41–1.00)
Retired 1.00 (0.79–1.27) 0.99 (0.78–1.27) 1.00 (0.79–1.27) 1.00 (0.79–1.27)
Unable 0.62 (0.45–0.85) 0.61 (0.44–0.84) 0.63 (0.46–0.86) 0.62 (0.45–0.85)
Age at diagnosis
21–49 0.97 (0.72–1.29) 0.97 (0.72–1.29) 0.96 (0.72–1.29) 0.97 (0.72–1.30)
50–64 REF REF REF REF
65 + 0.70 (0.55–0.88) 0.71 (0.56–0.89) 0.70 (0.55–0.88) 0.70 (0.56–0.89)
Nodes examined
0–5 REF REF REF REF
6 + 1.27 (0.97–1.67) 1.27 (0.97–1.67) 1.27 (0.97–1.67) 1.27 (0.97–1.67)
Treatment summary
Chemotherapy/no radiation 1.32 (1.07–1.63) 1.33 (1.08–1.64) 1.32 (1.07–1.63) 1.32 (1.07–1.63)
Chemotherapy+ radiation 1.29 (0.99–1.67) 1.30 (1.00–1.88) 1.28 (0.99–1.67) 1.29 (0.99–1.67)
Surgery only REF REF REF REF
Other/unknown 1.45 (0.89–2.35) 1.44 (0.89–2.34) 1.46 (0.90–2.37) 1.45 (0.89–2.35)
ICE race 0.83 (0.63–1.10)
ICE income 1.11 (0.81–1.53)
Poverty 1.00 (0.99–1.01)
Model AIC 2948.245 2948.601 2949.826 2950.115
Table 4. Explanatory Factors for Receipt of Individualized Recommendations for a Healthy Lifestyle
(Individualized Survivorship Care Plan)
Base model Adding ICE race Adding ICE income Adding poverty level
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Sex
Male 1.21 (1.02–1.43) 1.21 (1.02–1.43) 1.21 (1.02–1.43) 1.21 (1.02–1.43)
Female REF REF REF REF
Years since diagnosis 0.90 (0.82–0.99) 0.90 (0.82–0.99) 0.90 (0.82–0.99) 0.90 (0.82–0.99)
Nodes examined
0–5 REF REF REF REF
6 + 1.59 (1.22–2.06) 1.59 (1.23–2.06) 1.59 (1.23–2.06) 1.58 (1.22–2.05)
Treatment summary
Chemotherapy/no radiation 1.60 (1.31–1.95) 1.60 (1.31–1.95) 1.60 (1.31–1.95) 1.60 (1.31–1.95)
Chemotherapy+ radiation 1.25 (0.98–1.60) 1.26 (0.98–1.61) 1.25 (0.98–1.60) 1.25 (0.98–1.60)
Surgery only REF REF REF REF
Other/unknown 1.20 (0.77–1.88) 1.20 (0.77–1.88) 1.20 (0.77–1.88) 1.21 (0.77–1.90)
ICE race 0.92 (0.70–1.20)
ICE income 0.99 (0.73–1.34)
Poverty 1.00 (0.99–1.01)
Model AIC 3182.047 3183.620 3184.042 3183.568
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were more likely to receive an individualized SCP than
women or those who were diagnosed more distantly,
had fewer examined nodes, or were treated with sur-
gery only (Table 4). None of the neighborhood charac-
teristics improved the explanation of receipt of an
individualized SCP.
In the Table 5 we summarize the likelihood of not re-
ceiving any SCP. The likelihood of not receiving a SCP
was greatest for women, those looking for work or unable
to work, aged 65 or older at the time of diagnosis, and
those diagnosed with stage I cancer a longer time ago.
None of the geospatial characteristics changed any of
the individual explanatory factors. Of the geographic fac-
tors, none improved the best ﬁtting explanatory model
for not receiving a SCP. However, after controlling for in-
dividual level factors, ICE for income and neighborhood
poverty were signiﬁcantly associated with receipt of SCP,
indicating that individuals in economically advantaged
neighborhoods are more likely to receive a SCP.
In separate exploratory analyses (results not shown),
we added one at a time the two facility variables—
teaching status and size—to the base model of each
type of SCP to examine whether these variables im-
proved model ﬁt. Neither one improved the best ﬁtting
explanatory models for any of the SCP types, according
to the AIC.
Discussion
SCPs have been promoted as a key strategy to provide
cancer survivors with understandable information to
facilitate engagement in care during the transition
from active treatment to long-term survivorship. Over-
all, 80% of California CRC survivors in this study
reported receiving at least one type of SCP with speciﬁc
SCP types received by a minimum of 50% of patients,
outperforming targets set by the CoC.3 By comparison,
analyses of the 2010 data from the National Health
Interview Survey showed that 38.2% of individuals
with any type of cancer reported receiving a treatment
summary and 60.5% of cancer survivors reported re-
ceiving written advice on follow-up care.8 The higher
rate of SCPs observed in this study is likely due to
more recent collection of our study data and suggests
that by 2016, SCP delivery reached California state tar-
gets in the geographic areas we studied. It is worth not-
ing that 6.3% of survivors who completed the survey
reported not having cancer, which implies that they
were unaware of their cancer diagnosis and the need
for dedicated follow-up—the very issues addressed by
a SCP. California’s cancer control plan includes health
provider education and widespread efforts to integrate
SCPs into systems of care as strategies to achieve pos-
itive health outcomes.4 From the data available to us,
we cannot determine which of these strategies made
it possible for California to achieve this remarkable
prevalence of SCP delivery.
Despite this almost standardized delivery of SCPs, it
is notable that this study conﬁrmed prior ﬁndings of
disparities in SCP delivery.8,9 In this study of CRC sur-
vivors, we were able to link age, gender, time since
Table 5. Explanatory Factors for Not Receiving Any Survivorship Care Plan
Base model Adding ICE race Adding ICE income Adding poverty level
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Sex
Male 0.83 (0.67–1.03) 0.83 (0.67–1.03) 0.84 (0.68–1.04) 0.83 (0.67–1.03)
Female REF REF REF REF
Employment
Employed REF REF REF REF
Looking for work 1.85 (1.10–3.09) 1.84 (1.10–3.07) 1.85 (1.11–3.10) 1.84 (1.10–3.08)
Retired 1.04 (0.77–1.39) 1.03 (0.77–1.39) 1.04 (0.77–1.39) 1.04 (0.77–1.39)
Unable 1.58 (1.07–2.33) 1.56 (1.05–2.30) 1.51 (1.02–2.24) 1.53 (1.04–2.26)
Age at diagnosis
21–49 0.68 (0.45–1.02) 0.68 (0.45–1.02) 0.69 (0.46–1.04) 0.68 (0.45–1.03)
50–64 REF REF REF REF
65+ 1.57 (1.19–2.08) 1.58 (1.19–2.09) 1.58 (1.20–2.10) 1.58 (1.20–2.09)
Years since diagnosis 1.19 (1.06–1.34) 1.19 (1.06–1.34) 1.19 (1.06–1.35) 1.19 (1.06–1.34)
Stage
I REF REF REF REF
II 0.97 (0.75–1.26) 0.97 (0.75–1.26) 0.96 (0.75–1.25) 0.97 (0.75–1.25)
III 0.79 (0.61–1.02) 0.79 (0.61–1.02) 0.79 (0.61–1.02) 0.79 (0.61–1.02)
ICE race 0.88 (0.63–1.22)
ICE income 0.67 (0.46–0.99)
Poverty 1.01 (1.00–1.02)
Model AIC 2249.688 2251.086 2247.616 2249.364
Boehmer, et al.; Health Equity 2019, 3.1
http://online.liebertpub.com/doi/10.1089/heq.2019.0062
625
diagnosis, cancer stage, cancer treatments, number of
nodes examined, employment, marital status, and race
to the receipt of SCP. Thus, while we were able to show
that four out of ﬁve CRC patients in California receive
a SCP, the deviations we found suggest that providers
may prioritize SCP delivery to CRC patients whom
they perceive as more vulnerable, that is, those with
more advanced cancer stage or extensive treatment, or
younger patients, who may reap the most beneﬁts from
longitudinal follow-up. This is consistent with ﬁndings
of an Australian study of CRC patients, which noted a
pattern of ‘‘positive discrimination’’ in receipt of SCPs,
with survivors living in remote areas, non-English speak-
ers, and those with no experience accessing the health
care system more likely to receive a SCP.17 Similarly, in
our study, patient groups with greater difﬁculty accessing
the health care system—those who are unemployed,
racial/ethnic minority patients, and men who are
known to access health care less—had a greater likelihood
of receiving a SCP. Similarly, a prior study found that
non-White patients were more likely to receive SCPs, hy-
pothesizing that non-White racemay be a proxy formore
complex medical needs due to multiple comorbid condi-
tions and therefore a greater likelihood of receiving a
SCP.8 We found only two exceptions to this prioritiza-
tion pattern. First, patients with a more recent diagnosis
had a greater likelihood of receiving a SCP, most likely
due to being in closer proximity to the time in which
SCP receipt has become an expectation. Second, married
survivors had a greater likelihood of receiving follow-up
SCPs, possibly due to involvement of spousal caregivers
in the planning process, who may take particular interest
in follow-up care. The involvement of caregivers and
their perspectives regarding SCPs has previously been
noted as an unexplored aspect of SCP implementation.18
Conceptually, it has been recognized that neighbor-
hoods are determinants of health, including determinants
of cancer outcomes across the cancer continuum.10 We
therefore examined the contribution of geographic char-
acteristics on the quality of cancer care among California
CRC survivors. Others have successfully linked neighbor-
hood socioeconomic status (SES) or racial segregation
to cancer outcomes, above and beyond the effects of indi-
vidual socioeconomic status or race.10,19 In our data
neighborhood SES did not meaningfully improve the
explanatory model of receiving a SCP, despite the exis-
tence of an association between neighborhood SES and
receipt of SCPs, after individual level factors were con-
trolled. We suggest that cancer outcomes impacted by
neighborhood characteristics tend to depend on patient
behaviors, such as engaging in healthy behaviors or cul-
tural perceptions of treatments,20 whereas the delivery
of SCP is dependent on physician behaviors. Future
studies that use multilevel modeling of SCP delivery
should consider factors that affect physician behaviors,
such as hospital or practice characteristics.
Despite this study’s many strengths, we acknowledge
a number of limitations. Our study lacked health insur-
ance data, which would allow for a further determina-
tion of differences in SCP delivery. In addition, patients
had to be English speaking to be eligible for this study,
which prevented us from addressing linguistic differences
in SCP receipt. Because our data on facility characteristics
reﬂected only facilities at diagnosis and for the ﬁrst course
of treatment, we consider our investigation of possible
links between facility characteristics and SCP to be ex-
ploratory. Our selection of geographic areas with a high
number of CRC cases and high numbers of same-sex part-
nered households is a potential source of bias. While we
did not measure actual SCP content or query patients
about the perceived usefulness of the information they re-
ceived, our study’s assessment of speciﬁc types of SCP is a
strength of our study. Furthermore, because we obtained
acknowledgment of receipt of SCP from survivors directly,
our ﬁndings may have greater validity than electronic
medical record assessments alone, which can document
that SCPs are generated yet fail to elucidate how often
they are actually delivered to survivors.
Overall, the high rate of SCPs received by California
CRC survivors points to successful implementation of
quality improvement in cancer care. However, even in a
state with a largely successful distribution of SCPs, impor-
tant differences persist, which may stem from providers’
prioritization of patients perceived to have the greatest
need or beneﬁt. These ﬁndings suggest opportunities to
improve survivorship care further by eliminating dispar-
ities in SCP delivery so that all survivors can beneﬁt.
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